SG Americas Securities LLC Acquires New Shares in Harrow, Inc. (NASDAQ:HROW)

SG Americas Securities LLC acquired a new position in shares of Harrow, Inc. (NASDAQ:HROW) in the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 11,874 shares of the company’s stock, valued at approximately $534,000.

A number of other institutional investors also recently bought and sold shares of HROW. Private Capital Management LLC increased its position in shares of Harrow by 97.2% in the fourth quarter. Private Capital Management LLC now owns 2,794,497 shares of the company’s stock valued at $31,298,000 after buying an additional 1,377,597 shares in the last quarter. Woodmont Investment Counsel LLC increased its holdings in Harrow by 73.3% during the 1st quarter. Woodmont Investment Counsel LLC now owns 211,579 shares of the company’s stock valued at $2,799,000 after acquiring an additional 89,510 shares in the last quarter. Wasatch Advisors LP raised its position in Harrow by 28.3% during the first quarter. Wasatch Advisors LP now owns 388,132 shares of the company’s stock worth $5,135,000 after acquiring an additional 85,600 shares during the last quarter. China Universal Asset Management Co. Ltd. lifted its holdings in shares of Harrow by 66.0% in the first quarter. China Universal Asset Management Co. Ltd. now owns 6,745 shares of the company’s stock valued at $89,000 after purchasing an additional 2,682 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its position in shares of Harrow by 12.7% in the first quarter. BNP Paribas Financial Markets now owns 16,941 shares of the company’s stock valued at $224,000 after purchasing an additional 1,912 shares during the last quarter. 72.76% of the stock is currently owned by hedge funds and other institutional investors.

Harrow Stock Up 5.1 %

Shares of NASDAQ HROW opened at $53.49 on Wednesday. The firm has a market cap of $1.89 billion, a P/E ratio of -58.78 and a beta of 0.75. The company has a debt-to-equity ratio of 3.18, a quick ratio of 2.43 and a current ratio of 2.60. Harrow, Inc. has a 1 year low of $7.60 and a 1 year high of $54.31. The firm’s 50 day moving average price is $42.73 and its 200 day moving average price is $26.42.

Harrow (NASDAQ:HROW) last posted its quarterly earnings data on Wednesday, August 7th. The company reported ($0.13) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.25) by $0.12. The business had revenue of $48.94 million for the quarter, compared to analysts’ expectations of $42.78 million. Harrow had a negative return on equity of 40.59% and a negative net margin of 21.78%. As a group, sell-side analysts anticipate that Harrow, Inc. will post -0.14 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on HROW shares. Lake Street Capital lifted their price objective on Harrow from $45.00 to $55.00 and gave the stock a “buy” rating in a research report on Friday, October 4th. B. Riley reissued a “buy” rating and issued a $50.00 price target on shares of Harrow in a report on Thursday, August 29th. Finally, Craig Hallum increased their price objective on Harrow from $45.00 to $65.00 and gave the company a “buy” rating in a research note on Friday, October 4th.

Harrow Profile

Harrow, Inc operates as an ophthalmic-focused healthcare company. The company owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding business. The company was formerly known as Imprimis Pharmaceuticals, Inc and changed its name to Harrow Health, Inc in December 2018. Harrow Health, Inc was incorporated in 2006 and is headquartered in Nashville, Tennessee.